The cholesterol lowering effect of Lac-β-CyD was drastically impaired by co-treatment with AF, indicating that ASGPR-mediated endocytosis of Lac-β-CyD is important to lower free cholesterol levels in endolysosomes of the cells. The gene discussed is ASGR1; the disease is atrial fibrillation.